Strep A Treatments: Supply
Debate between Maria Caulfield and Khalid Mahmood(1 year, 11 months ago)
Commons ChamberRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Urgent Questions are proposed each morning by backbench MPs, and up to two may be selected each day by the Speaker. Chosen Urgent Questions are announced 30 minutes before Parliament sits each day.
Each Urgent Question requires a Government Minister to give a response on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
Maria Caulfield
I thank my hon. Friend for raising this important point. UKHSA is looking at the data on this outbreak and previous ones. I am happy to meet him to discuss that, particularly if he has details of treatment options he feels are not being pursued at the moment.
Mr Khalid Mahmood (Birmingham, Perry Barr) (Lab)
Does the Minister accept that no production lines in UK pharmaceutical suppliers are operating, because we have contracted out all our supplies to China and India, which manufacture all the drugs? Both countries have not signed up to the pharmaceutical inspection and co-operation scheme, which ensures homogenisation of good manufacturing practices. The UK manufacturers have to apply that whereas the overseas manufacturers do not. Therefore, we have over 10 manufacturers of pharmaceuticals who are not able to produce the right antibiotics because of the unfair discrimination against them by the Government. Will she ensure that this is put right before Christmas so that our local, British pharmaceutical manufacturers can produce the right antibiotics to give to all our children who need them so desperately?
Maria Caulfield
Perhaps if the hon. Gentleman had not been heckling me throughout my opening remarks, he would have heard that we are working with manufacturers and wholesalers across the country. Manufacturers are opening up new production lines and those supplies will be hitting pharmacy shelves very soon.